Neuroleptic Malignant Syndrome: A Review for Intensivists-Reference-Cited by-同舟云学术

Neuroleptic Malignant Syndrome: A Review for Intensivists

Published:1994-09 Issue:5 Volume:9 Page:227-234
ISSN:0885-0666
Container-title:Journal of Intensive Care Medicine
language:en
Short-container-title:J Intensive Care Med

Author:

Prager Laura M.¹,Millham Frederick H.²,Theodore Stern A.³

Affiliation:

1. Department of Child Psychiatry

2. Associate Director, Surgical Intesive Care Units, Boston City Hospital and The University Hospital, Boston, MA.

3. Director, Resident's Psychiatric Consultation Service, Massachusetts General Hospital, and Harvard Medical School;

Abstract

Neuroleptic malignant syndrome (NAIS) is arare, potentially life-threatening disorder that results from the use of neuroleptics, a class of drugs that is being used with increasing frequency in intensive care units (ICUs). Unfortunately, critically ill patients typically have coexisting conditions that make accurate diagnosis of NAIS difficult and complicate treatment decisions. Diagnostic criteria, risk factors, and treatment options for NMS are discussed; case examples are provided.

Publisher

SAGE Publications

Subject

Critical Care and Intensive Care Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/088506669400900502

Reference47 articles.

1. Epidemiology of Neuroleptic Malignant Syndrome

2. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome

3. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroleptic malignant syndrome in trauma patient;Burns;2015-09

2. Clinical Experience With the Management of Schizophrenia in the General Hospital;Psychosomatics;2003-01

3. Neuroleptic malignant syndrome in a burn patient;Burns;1998-09